| Datum | Zeit | Quelle | Überschrift | Symbol | Firma |
| 13/06/2024 | 22h30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 13/06/2024 | 22h30 | Business Wire | Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 06/06/2024 | 21h30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 06/06/2024 | 21h30 | Business Wire | Novo Integrated Sciences’ Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 05/06/2024 | 21h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 05/06/2024 | 21h00 | Business Wire | Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 03/06/2024 | 21h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 03/06/2024 | 21h00 | Business Wire | Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 31/05/2024 | 15h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 31/05/2024 | 15h00 | Business Wire | Novo Integrated Sciences’ Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 30/05/2024 | 22h30 | Business Wire | Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 15/04/2024 | 22h30 | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 11/04/2024 | 23h00 | Business Wire | Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 26/03/2024 | 19h30 | Business Wire | Novo Integrated Sciences Provides Update on Certain Current Actions and Events | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 21/02/2024 | 22h05 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 21/02/2024 | 22h05 | Business Wire | Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd. | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 20/02/2024 | 20h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 20/02/2024 | 20h00 | Business Wire | Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 16/02/2024 | 20h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 16/02/2024 | 20h00 | Business Wire | Novo Integrated Sciences Appoints New President | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 15/02/2024 | 23h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 06/02/2024 | 18h00 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 22/01/2024 | 22h31 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 22/01/2024 | 22h30 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 22/01/2024 | 22h30 | Business Wire | Novo Integrated Sciences Reports Fiscal Year 2024 First Quarter Financial Results | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 16/01/2024 | 22h05 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 19/12/2023 | 22h45 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 19/12/2023 | 22h30 | Business Wire | Blacksheep Trust Files Partial Assignment of $1 Billion Dollar Gold Backed Bond to Novo Integrated Sciences | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 14/12/2023 | 23h01 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:NVOS | Novo Integrated Sciences Inc |
| 14/12/2023 | 23h00 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:NVOS | Novo Integrated Sciences Inc |